Radionuclides for medical use

US7794691B2 · kind B2 · utility

Assignee

• THE EUROPEAN COMMUNITY, REPRESENTED BY THE EUROPEAN COMMISSION · BE

Inventors

• Alfred Morgenstern · Karlsruhe, DE
• Christos Apostolidis · Heidelberg, DE
• Roger Molinet · Blankenloch, DE
• Klaus Luetzenkirchen · Deggendorf, DE

Key dates

• Filing date: Jun 25, 2004
• Grant date: Sep 14, 2010
• Expiry date: Jan 22, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods of using Th-226 or mother radionuclides thereof, namely U-230 or Th-226, in medicine. These radionuclides are particularly appropriate for the treatment of human and/or non-human mammals, in particular for therapeutic, diagnostic (detection/imaging), prophylactic and pain palliation purposes. These radionuclides may be used in various forms for treatment and/or diagnostic purposes, in particular in cationic form or in the form of radioconjugates or bone-targeting complexes. Methods of making such radionuclides.